Newsroom | 23947 results

BOCA RATON, Fla.--(BUSINESS WIRE)--Il Cataltheia Group e la sua controllata, Bruno Vision Care LLC, azienda leader nell'innovazione della salute degli occhi, oggi ha annunciato che la Food and Drug Administration (FDA) statunitense ha approvato la prima e unica lente a contatto morbida per la presbiopia che utilizza la tecnologia brevettata di progettazione ottica Extended Depth of Focus (EDOF), dando il via alla distribuzione commerciale negli Stati Uniti. Deseyne® offre una focalizzazione flu...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q4 2025 Earnings Snapshot through a link on...

SAN FRANCISCO--(BUSINESS WIRE)--Combining Hippocratic AI’s safety-first technology and health care specialization with BCG’s strategic, operational, and AI transformation expertise...

BELLINGHAM, Washington--(BUSINESS WIRE)--Oggi l’apposito comitato SPIE, la società internazionale di ottica e fotonica, ha annunciato i nomi dei premiati con i suoi prestigiosi riconoscimenti annuali. Questi riconoscimenti attestano progressi trasformativi in diversi ambiti professionali – medicina, astronomia, litografia, metrologia ottica, progettazione ottica e leadership nella community – e vengono conferiti sia per risultati tecnici sia per il servizio dedicato a SPIE e il sostegno alla su...

BELLINGHAM, Washington--(BUSINESS WIRE)--El Comité de Premios de SPIE —la sociedad internacional dedicada a la óptica y la fotónica— anunció los destinatarios de sus prestigiosos premios anuales. Al rendir homenaje a avances transformadores en un amplio abanico de áreas profesionales —que incluyen medicina, astronomía, litografía, metrología óptica, diseño óptico y liderazgo comunitario— los premios de la Sociedad reconocen tanto los logros técnicos como el servicio comprometido a SPIE y el apo...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced preliminary financial results and business updates for the fourth quarter and year-ended December 31, 2025. Preliminary Fourth Quarter and Full-Year 2025 Financial Results (unaudited) Total fourth quarter and full year revenue expected to be approximately $20.7 million and...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated framework designed to accelerate AI-enabled drug discovery. Lilly TuneLab was established to make advanced AI/ML model...

BOSTON--(BUSINESS WIRE)--Elucid today announced that, effective January 1, 2026, its Plaque-IQ™ coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT®) designation, alongside increasingly widespread coverage and reimbursement from both public and private payors. Together, these developments underscore the clinical value of coronary plaque analysis and establish favorable conditions for broader adoption of the technology. Quantitative coronary plaque analysis...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced a series of corporate and pipeline updates. GCTx unveiled its initial pipeline programs focused on demyelinating neurological disorders, including multiple sclerosis (MS), and a regenerative cell therapy program for metabolic diseases, including Type 1 Diabetes. B...

HANAU, Germany--(BUSINESS WIRE)--The Bruker Energy & Supercon Technologies (BEST) division, a segment of Bruker Corporation (Nasdaq: BRKR), today announced two multi-year supply agreements for Bruker’s latest superconductors, which are used by global radiology companies to build their next generations of magnetic resonance imaging (MRI) magnets. The combined order value of the two agreements is approximately $500 million in expected future BEST revenues, with different agreement duration pe...